Announcement on Company Re-certified as High-tech Enterprise
Filed with SSE · · 1 page · Chinese
Beijing Konruns Pharmaceutical Co., Ltd. on 6ix
Earlier from Beijing Konruns Pharmaceutical
- Announcement on Resolutions of the 18th Meeting of the 4th Board of Supervisors
- Announcement on Implementing Repurchase and Cancellation under 2023 Restricted Stock Incentive Plan
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Result of Shareholding Reduction by Shareholder
- Report for Q3 2025
Later from Beijing Konruns Pharmaceutical
- Announcement on FDA Approval for Clinical Trials of KC1086 Project
- Announcement on Election of Employee Director
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Earnings Preannouncement for 2025
- Announcement on Using Partial Idle Raised Funds for Cash Management and Redemption
Follow Beijing Konruns Pharmaceutical into a list and get an email when it puts out news.
Follow Beijing Konruns Pharmaceutical